Prediction of Temporomandibular Involvement in Juvenile Idiopathic Arthritis
1 other identifier
observational
62
1 country
1
Brief Summary
Purpose and aims The general aim of this project is to improve the diagnostic methods for disease activity and identify predictive factors (clinical and radiographic factors, pro- and anti-inflammatory mediators in saliva and plasma) for temporomandibular joint (TMJ) involvement in juvenile idiopathic arthritis (JIA). The hypothesis is that self-reported pain and impaired jaw function together with clinical findings correlates well with radiological signs of jaw involvement. Null hypothesis: Self-reported pain, impaired jaw function and clinical findings do not correlate with radiological signs of jaw involvement. Study 1 The aim of this study is to investigate which findings from the patient history and from clinical examination that is of significance for diagnostics of TMJ involvement in patients with JIA both in a short- and long-term perspective. The patients will be followed-up during two years. They will undergo a clinical examination according to Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD; Dworkin and LeResche 1992) once a year and a telephone follow-up sixth months after the clinical examination. Further, the clinical findings from the orofacial regions will be compared to their general disease activity. Study 2 The aim of the second study is to correlate radiological findings and clinical findings in order to investigate any early radiological signs of disease activity and progression but also to compare the radiographic examination using conventional panoramic technique with computer tomography (CT).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2011
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2011
CompletedFirst Submitted
Initial submission to the registry
June 30, 2014
CompletedFirst Posted
Study publicly available on registry
August 18, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedMarch 6, 2023
March 1, 2023
6.5 years
June 30, 2014
March 3, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
Clinical findings in children with JIA
To find similarities in patients with JIA according to RDC-TMD (a clinical protocol validated for children)
2 years
Radiographic findings in children with JIA
Repeated radiographic examination
Two years
Patient history
Repeated interview on function and pain in the jaw area
Two years
Study Arms (1)
Juvenil Idiopathic Arthritis
The group consists of children age 7-14 with an diagnosis of active Juvenile Idiopathic Arthritis.
Eligibility Criteria
One-hundred consecutive patients with active JIA, as diagnosed by the Department of Pediatric Rheumatology, Astrid Lindgrens Barnsjukhus, Karolinska University Hospital will be included.
You may qualify if:
- age between 7 and 14 years
- a diagnosis of JIA according to the International League of Associations for rheumatology (ILAR) The parents of the patients and/or the patients will give their verbal and written informed consent to participate in the study according to the permission from the regional ethical committee 2011/2:1.
You may not qualify if:
- current malignancies
- TMJ surgery or trauma within two years
- recent intra-articular glucocorticoid injection in TMJ (within 1 month)
- other conditions or diseases than JIA that may cause orofacial pain.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Malin Collinlead
- Karolinska Institutetcollaborator
Study Sites (1)
Folktandvården Stockholmslän AB
Stockholm, 14463, Sweden
Biospecimen
whole blood, serum,saliva
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Britt Hedenberg Magnusson, PhD DDS
Karolinska Institutet
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- DDS, PhD-student
Study Record Dates
First Submitted
June 30, 2014
First Posted
August 18, 2014
Study Start
February 1, 2011
Primary Completion
August 1, 2017
Study Completion
December 1, 2023
Last Updated
March 6, 2023
Record last verified: 2023-03